Revolutionary platelet score offers better risk assessment for heart attacks

Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels.

Lupin wins first FDA approval for generic version of Boehringer Ingelheim blockbuster Spiriva

Indian drugmaker Lupin today said it won FDA approval for the first generic version of Spiriva, a blockbuster COPD drug from Boehringer Ingelheim. The generic,

June 22, 2023

Investment firm launches with $100M for bioprocessing entrepreneurs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 18, 2024

Dräger on track to meet annual forecast after a solid first half-year – Biotech Investments

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Half Year Report/Half Year Results Drägerwerk AG & Co. KGaA: Dräger on track to meet annual

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.